Recent 8-K filings for ADIL

Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.

• May 11, 2026 12:40 UTC earnings item 2.02item 9.01

  Adial Pharma Q1 net loss $2M; cash $4.6M; FDA policy shift may aid AD04 path

source · ADIL on sec.gov